What does statutory insurance (GKV) actually pay for?
Here is the short version: your statutory insurance pays for prevention and basic screening. A few of those checks happen to help with longevity goals. Most don't.
So let's split it into what you get, what's covered when there's a medical reason, and what you'll be paying for yourself.
The regular prevention catalogue:
- Health check-up (Check-up 35) every 3 years from 35: history, blood pressure, lipid panel (total cholesterol, LDL, HDL, triglycerides), fasting glucose, urine dipstick, plus a one-time hepatitis B/C test. Between 18 and 34 you get one check-up, with blood tests only if you have risk factors [14]. ApoB, Lp(a) and HbA1c are not included. Details in the Check-up 35 guide.
- Skin cancer screening from 35, every 2 years
- Colorectal cancer screening from 50: an iFOBT stool test (it checks for hidden blood in your stool) every 2 years, or two screening colonoscopies 10 years apart. Since 1 April 2025 the rules are the same for women and men, after a decision on 16 January 2025 by the G-BA (the body that decides what statutory insurance covers) [1].
- Breast cancer screening: mammography every 2 years, ages 50 to 75. The upper age used to be 69. Women aged 70 to 75 have been included since 1 July 2024. An amendment to Germany's breast screening ordinance (Brustkrebs-Früherkennungs-Verordnung), in force since 5 March 2026, now legally allows mammography for women aged 45 to 49 [8]. Whether the GKV actually pays for that group is a separate question. A G-BA decision was announced for October 2026 [19]. Even after a yes, invitations can only start once the patient leaflet is revised, which is planned for April 2027.
- Lung cancer screening (new since April 2026): a low-dose CT every 12 months for current and former heavy smokers aged 50 to 75 with at least 25 years of smoking and 15 pack-years (one pack-year means 20 cigarettes a day for a year) [9]. It is the only CT the GKV pays for as pure screening.
- Cervical cancer screening
- Prostate exam from 45
- Vaccinations per STIKO
Medications you get covered when there's a clear reason:
- Blood pressure drugs for confirmed hypertension
- Statins if you already have cardiovascular disease (your heart and blood vessels) or a high risk, meaning a 10-year event risk above 10 percent, plus a few special cases such as familial hypercholesterolaemia. A mildly raised risk alone is not enough [18]
- Metformin for type 2 diabetes
- HRT (hormone therapy) when menopause calls for it
- GLP-1 agonists for diabetes
What GKV does NOT cover:
- Expanded blood panels (ApoB, Lp(a), hsCRP, omega-3 index, full hormone panels, microbiome)
- Biological or epigenetic age tests (these read the chemical tags sitting on your DNA, which shift as you get older)
- Whole-body MRI as routine screening
- Coronary calcium score
- VO2 max tests outside a cardiology indication
- DEXA scan (unless osteoporosis is suspected)
- CGM (a continuous glucose monitor) without diabetes
- GLP-1 for weight loss without diabetes (excluded by law as a lifestyle drug)
- Longevity consultations at private practices
- IV therapies
What does a longevity check-up actually cost? (2026 prices)
Expect roughly €150 to €450 for a full longevity blood panel, €50 to €150 for a DEXA scan, €150 to €300 for a coronary calcium score, and €800 to €2,500 for a whole-body MRI in 2026. The cheap diagnostics carry the strongest evidence, the expensive imaging the weakest.
A longevity check-up is not a fixed product, it is a shopping basket. Every private practice bundles a different package, so here are the building blocks one by one, with real reference prices from large and mid-size German cities. The ranges are wide on purpose. The low end is a budget lab, the high end is a premium private practice for the exact same test. The "Does GKV pay?" column shows what statutory insurance does when your doctor has not documented a medical reason. "IGeL" (Individuelle Gesundheitsleistungen) means a self-pay service a practice offers on top of what the Kasse covers.
| Service | 2026 price range | Does GKV pay? |
|---|---|---|
| Full longevity blood panel (30 to 60 markers) | €150 to €450 | No, IGeL |
| ApoB, Lp(a) | €25 to €80 | Only with an indication |
| Full hormone panel | €150 to €300 | Only with an indication |
| Omega-3 index | €40 to €80 | No, IGeL |
| Microbiome analysis | €250 to €500 | No, IGeL |
| Epigenetic age test | €250 to €500 | No, IGeL |
| Heavy metal test | €100 to €250 | Only with an indication |
| DEXA scan | €50 to €150 | Only for suspected osteoporosis |
| Coronary calcium score | €150 to €300 | No, IGeL |
| Carotid intima-media measurement (ultrasound of the neck artery wall) | €70 to €180 | Only with an indication |
| Whole-body MRI | €800 to €2,500 | No, as routine screening |
| Cardiac MRI | €400 to €800 | Only with an indication |
| Spiroergometry (measures VO2 max directly) | €150 to €300 | Only with a cardiology indication |
| Resting and stress ECG | €50 to €150 | Only with an indication |
| IV vitamin therapy | €60 to €250 per session | No |
| NAD+ IV | €200 to €500 per session | No |
| IHHT (breathing low- and high-oxygen air in intervals) | €30 to €80 per session | No |
| Cryotherapy chamber | €20 to €50 per session | No |
| Hyperbaric oxygen therapy | €100 to €300 per session | No, as a longevity application |
| Longevity private practice, first visit | €200 to €500 | No |
| Longevity private practice, follow-up | €100 to €300 | No |
| Longevity clinic, check-up package | €1,500 to €5,000 | No |
| Longevity coaching subscription (with blood panel) | €50 to €200 per month | No |
| Wearable-based program | €20 to €100 per month | No |
| Heilpraktiker first consultation | €80 to €200 | No, only via supplementary cover |
Cheap does not always mean useful. IGeL-Monitor rates a carotid ultrasound for stroke prevention and a screening ECG in people without symptoms as "tendenziell negativ" (leaning negative) [21, 22].
The coronary calcium score comes with a footnote. The G-BA added CT coronary angiography (CCTA) to the GKV catalogue on 18 January 2024, and reimbursement kicked in on 1 January 2025. But that only counts if you have stable chest pain and a suspected CAD (coronary artery disease) [17]. The pure Agatston screening (the calcium score itself), the kind you book just to check, stays self-pay (an IGeL).
Is PKV or a supplementary plan worth it?
Short answer: usually not for longevity alone. Here is the longer version.
Private insurance (PKV) contracts vary a lot. Many plans do pay for noticeably more longevity-relevant stuff:
- Expanded lab diagnostics on a physician's order
- Non-physician services (a Heilpraktiker, the German non-medical practitioner) to some extent
- Longer prevention appointments
- Extra check-ups or imaging without a medical reason, but only if your tariff explicitly includes a prevention budget [15]
Still, PKV is usually not worth it just for longevity. Stretch the extra premium over a few decades and it tends to cost you more than the longevity benefit is actually worth.
Already in the GKV and want to bolt on a supplement? You have three options:
- Outpatient supplementary: often covers Heilpraktiker and expanded prevention
- Heilpraktiker supplementary: just for Heilpraktiker services
- Prevention supplementary: expanded GKV prevention
Typical premiums run €10 to €50 per month. They pay back anywhere from 50 to 80 percent, depending on the Tarif, often with caps that grow over the first years.
One tip before you sign: read the fine print. Check the waiting periods, the yearly caps, and which methods are actually covered. That last one trips people up.
How should you actually spend your self-pay budget?
For most people the sweet spot is a yearly expanded blood panel plus a wearable, a DEXA and VO2 max test, and a longevity check-up now and then: roughly €550 to €1,150 per year. Skip routine whole-body MRI unless you are genuinely high-risk, and screen every service against the evidence first.
Before you pay for anything, do one thing: look it up on IGeL-Monitor. It's run by the Medizinischer Dienst Bund, and at igel-monitor.de they publish independent benefit-harm ratings for self-pay services. As of 18 June 2026 they have rated 61 services: 0 positive, 3 leaning positive, 27 unclear, 25 leaning negative, 6 negative [3]. Not one rated service earns a clear positive.
A heads-up on the big-ticket ones. Whole-body MRI as a preventive screen isn't in the IGeL-Monitor catalogue at all. The closest entries are MRT der Brust zur Krebsfrüherkennung (rated "unklar" since the June 2025 reassessment) and MRT zur Früherkennung einer Alzheimer-Demenz ("tendenziell negativ"). The ACR (American College of Radiology) puts it plainly: there is no documented evidence that whole-body screening in people without symptoms or risk factors helps them live longer [13].
A few more that people ask about. HBOT (hyperbaric oxygen) for Long-COVID is rated "unklar." NAD+ IV drips, the Myers cocktail, and high-dose Vitamin C IV outside cancer care aren't in the catalogue at all. The critical takes on those come from GWUP (Germany's skeptics' society) and the skeptic literature, not from IGeL-Monitor, so check the specific service before you hand over your card.
Now, the part you came for. Here's a priority ladder that works for most people.
Tier 1. Baseline (free or already in GKV):
- Use regular GKV prevention
- No smoking, little alcohol
- Daily movement, strength training 2 to 3 times a week
- Track strength with a grip strength test. Many gyms and practices have a dynamometer (a hand-grip meter)
- 7 to 8 hours of sleep
Tier 2. Low effort, high value (€300 to €700 per year, plus a wearable):
- Yearly expanded blood panel (including ApoB, Lp(a), hsCRP, HbA1c, fasting insulin, vitamin D, B12, ferritin)
- DEXA every 2 to 3 years
- Yearly VO2 max test
- A wearable (Whoop, Oura, Garmin)
Tier 3. Medium effort (€500 to €1,500 per year):
- Yearly longevity private practice visit
- Coronary calcium score (every 5 years if normal)
- Epigenetic age test every 2 to 3 years
- IV vitamin therapy for documented deficiencies
Tier 4. High effort (€1,500 and up per year):
- Whole-body MRI only if risk-stratified (see below), not as routine
- A CGM (continuous glucose monitor) without diabetes
- NAD+ IV programs
- Off-label drugs (see rapamycin guide)
For most people, the sweet spot is Tier 1 plus Tier 2, with Tier 3 now and then. That lands around €300 to €800 per year, plus up to €20 to €30 per month (€240 to €360 a year) if you pick a subscription wearable like Whoop (Garmin needs no subscription). With a subscription wearable, call it roughly €550 to €1,150 a year.
Where your next euro should go, by budget
Another way to see it: by what's in your wallet. It works across Germany, Austria, and Switzerland (just swap in the local name for the GP check-up).
| Annual budget | What you get | Guide price |
|---|---|---|
| €0 | GKV check-up (Germany, every 3 years from 35) or the Austrian Vorsorgeuntersuchung (free every year), the sit-rise test (get up off the floor without using your hands, a surprisingly strong predictor of how long you'll live [7]), a grip-strength self-assessment, the Rockport walk test (a brisk 1-mile walk to estimate VO2 max) | €0 (handheld dynamometer ~€40 one-time, or a simple squeeze test) |
| €200 | Expanded blood panel as IGeL (ApoB, Lp(a), hsCRP, fasting insulin, HbA1c), a home omega-3 index test (dried blood spot), the rest for basic vitamin D testing or top-ups | ~€150 + ~€45 |
| €500 | Everything above, plus a DEXA scan, a VO2 max test at a sports medicine centre, a Polar H10 chest strap with HRV4Training, basic supplements for known deficiencies (vitamin D, omega-3, creatine) | €50 to €150 + €100 to €200 + ~€100 one-time |
| €1,500 | Everything above, plus a yearly biological age test: TruDiagnostic TruAge Complete (an epigenetic DNA methylation test, plus EU import VAT) or GlycanAge (measures sugar chains on your antibodies, not an epigenetic test; lab in Zagreb, Croatia, EU-internal shipping). Plus one longevity physician visit (Zusatzbezeichnung Naturheilverfahren or Ernährungsmedizin, or a Präventivmedizin Fortbildung) | ~€500 or ~€300 + ~€300 |
| €3,000+ | Everything above, plus whole-body MRI only if medically indicated (see the risk rule below), NAD+ IV if you prefer it, a full longevity private-practice membership (quarterly visits, labs included) | €800 to €2,500 for the MRI, plus membership fees |
Switzerland has no free yearly general check-up like Austria's. Basic insurance (OKP/LAMal) covers defined prevention services, such as mammography from 50, colorectal screening and vaccinations, plus medically necessary care. For ordinary care you pay your deductible (Franchise) and a co-pay (Selbstbehalt). Organised screening programmes skip the Franchise. You pay only the 10% Selbstbehalt.
Supplementary plans at a glance (Germany, typical features as of 2026)
Treat these as rough guides, not promises. Always check the specific Tarif before you sign.
- Hallesche AE.3 (GKV top-up): Heilpraktiker costs 50%, up to €260 of invoices in year 1, €520 in year 2 and €780 from year 3. Don't mix this up with NK.Bonus. That's a full private insurance (Krankenvollversicherung), not a top-up, and it's closed to new customers right now. Hallesche's open full PKV line is NK.select S/L/XL, with NK.select FLEX as the option to switch plans.
- Münchener Verein and Barmenia also sell Heilpraktiker and outpatient top-ups. Check the current Tarif for the percentage, the caps and the premium.
Before you sign, look at three things: the waiting periods (often 3 to 8 months), the excluded methods (bioresonance is commonly out), and which labs are in-network.
Physician pathway
Want prescriptions (rapamycin off-label, HRT, GLP-1 on indication) plus lifestyle coaching in one place? Then skip the Heilpraktiker route. Go straight to a physician with a Zusatzbezeichnung in Naturheilverfahren or Ernährungsmedizin. Watch the labels here: Präventivmedizin is only a curricular Fortbildung (a course you complete), not a formal Zusatzbezeichnung. The Heilpraktiker longevity guide walks you through searching Ärztekammer-Suche and arzt-auskunft.de, plus what a typical first visit looks like.
Whole-body MRI: a risk-stratified rule
Whether whole-body MRI makes sense depends on your personal risk. Here is a simple rule. The whole-body MRI screening guide goes deeper on the trade-offs.
Consider whole-body MRI if this is true for you:
- Li-Fraumeni syndrome (you carry an inherited TP53 gene mutation): a yearly whole-body MRI is part of the Toronto Protocol, the surveillance plan for this syndrome [4]
Two situations often get lumped in, but they call for something else first:
- A strong family history of early cancer (2+ first-degree relatives with cancer before 55): start with genetic counselling. Whole-body MRI only makes sense if it confirms a syndrome whose surveillance plan includes it.
- Neurological symptoms need a targeted MRI of the brain or spine, not a whole-body scan. Your Kasse pays for that one.
BRCA1/2 carriers do not need whole-body MRI for standard surveillance. BRCA1 and BRCA2 are inherited gene changes that raise breast and ovarian cancer risk. The recommended plan is an annual breast MRI plus mammography, and steps that lower ovarian cancer risk. The US NCCN guideline on hereditary breast and ovarian cancer (HBOC) starts mammography at 30. The German S3-Leitlinie Mammakarzinom and the German HBOC consortium add breast ultrasound and start mammography at 40, every one to two years [5, 6, 12].
For everyone else, here's the catch: when your real risk is low, false-positive findings are common. And a false alarm means anxiety, more tests, and sometimes a procedure you never needed. For truly low-risk people, that downside likely outweighs the upside. A focused coronary calcium CT and a DEXA give you far more useful evidence per euro.
Frequently asked questions
How much does a longevity check-up cost in Germany?
Does health insurance pay for a longevity coach?
Can a longevity coach bill German health insurance?
Does insurance pay for a biological age test?
Which self-pay investments are most worth it?
Does German public insurance pay for an MRI or a DEXA scan?
Is PKV worth it just for longevity?
Does insurance pay for Ozempic or Wegovy for longevity?
Is there a good Heilpraktiker supplementary insurance?
Can I deduct self-pay health costs from my German taxes?
Sources
- Gemeinsamer Bundesausschuss. (2025). G-BA Beschluss vom 16. Januar 2025 zur Krebsfrüherkennungs-Richtlinie (Darmkrebs-Screening ab 50, geschlechtsneutral)
- Bundesministerium der Justiz. (2024). §34 SGB V, Lifestyle-Arzneimittel-Ausschluss (AM-RL Anlage II)
- Medizinischer Dienst Bund. (2026). IGeL-Monitor: Bewertungen von Selbstzahlerleistungen (Stand 18. Juni 2026)
- Villani A, Shore A, Wasserman JD, et al. (2016). Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study. Lancet Oncologydoi:10.1016/S1470-2045(16)30249-2
- National Comprehensive Cancer Network. (2026). NCCN Guidelines: Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate
- AWMF / Deutsche Krebsgesellschaft. (2026). S3-Leitlinie Mammakarzinom (Früherkennung, Diagnostik, Therapie und Nachsorge), Version 5.1, AWMF 032-045OL
- de Brito LBB, Ricardo DR, de Araújo DSMS, et al. (2012). Ability to sit and rise from the floor as a predictor of all-cause mortality. European Journal of Preventive Cardiologydoi:10.1177/2047487312471759
- Bundesministerium für Umwelt, Klimaschutz, Naturschutz und nukleare Sicherheit (BMUKN). (2026). Zweite Verordnung zur Änderung der Brustkrebs-Früherkennungs-Verordnung (BGBl. 2026 I Nr. 53; ausgefertigt 27. Februar 2026, verkündet 4. März 2026, in Kraft 5. März 2026)
- Gemeinsamer Bundesausschuss. (2026). Lungenkrebs-Früherkennung für Raucherinnen und Raucher (Niedrigdosis-CT, Krebsfrüherkennungs-Richtlinie)
- Zentrale Prüfstelle Prävention (Kooperationsgemeinschaft gesetzlicher Krankenkassen). (2026). Zertifizierung von Präventionsangeboten nach § 20 SGB V
- Bundesministerium der Justiz. (2026). § 33 EStG, Außergewöhnliche Belastungen
- Deutsches Konsortium Familiärer Brust- und Eierstockkrebs. (2026). Intensivierte Früherkennung
- American College of Radiology. (2023). ACR Statement on Screening Total Body MRI
- Gemeinsamer Bundesausschuss. (2026). Gesundheitsuntersuchungen (Check-up)
- Bundesministerium der Justiz. (2026). § 192 VVG, Vertragstypische Leistungen des Versicherers
- Gemeinsamer Bundesausschuss. (2024). Tragende Gründe zum Beschluss Arzneimittel-Richtlinie/Anlage II: Semaglutid (Wegovy) vom 21. März 2024
- Gemeinsamer Bundesausschuss. (2024). Neue ambulante Leistung: Bildgebendes Verfahren zum Abklären von koronarer Herzkrankheit
- Gemeinsamer Bundesausschuss. (2026). Arzneimittel-Richtlinie Anlage III Nummer 35 (Lipidsenker), Tragende Gründe zur Einleitung eines Stellungnahmeverfahrens vom 11. August 2026
- Gemeinsamer Bundesausschuss. (2026). Mammographie-Screening zur Früherkennung von Brustkrebs: G-BA berät über Absenkung der Altersgrenze auf 45 Jahre (Pressemitteilung vom 16. April 2026)
- European Medicines Agency. (2026). Wegovy: EPAR, Product Information (therapeutic indication, section 4.1)
- Medizinischer Dienst Bund (IGeL-Monitor). (2026). Ultraschall der Halsschlagadern zur Schlaganfallvorsorge
- Medizinischer Dienst Bund (IGeL-Monitor). (2026). EKG zur Früherkennung einer koronaren Herzerkrankung
- Bundesministerium der Justiz. (2026). § 64 EStDV, Nachweis von Krankheitskosten
Share experiences with longevity practices
At chapter events, members swap notes on specific private practices, labs, and providers.
Events near meExperts in this field
Speakers from the Longevity Switzerland community on this topic
Related guides
Peter Attia & Outlive (DACH perspective)
The Four Horsemen, Medicine 3.0, and the Centenarian Decathlon. Attia's framework explained for a DACH audience.
Heilpraktiker and longevity
What German Heilpraktiker can and cannot offer in a longevity context. The legal framework and how it differs from physicians.
Biological age tests and German health insurance
Are biological age tests covered by Krankenkasse? What GKV and PKV pay for, IGeL pricing, and how to choose self-pay test providers
Whole-body MRI screening
Prenuvo and Neko are coming to Europe. The honest case: no mortality trial, a 95% incidental-finding rate, and the one niche it fits.
Created by Maurice Lichtenberg, Founder, Longevity Cities
The information provided here is for educational purposes only. Longevity Switzerland does not provide medical advice, diagnosis, or treatment. Always seek the advice of qualified healthcare providers with questions regarding medical conditions.
